I seem to recall that people with terminal cancer, who took the Coalition/Atos work capability assessment, were told they were fit for work. I’m wondering if this sale of cancer research to the private sector is an attempt to justify those decisions retrospectively. Sort of: “We’ll get our buddies in private enterprise to rubber-stamp it and then we’ll be off the hook!” Of course, Interserve is likely to make millions out of this as cancer affects one in three of us. Perhaps it’s time to look up the list of MPs’ interests and find out who has shares?
(Not satire – unfortunately)
(UPDATE – another private company ISS, not INTERSERVE are running the ICR services. My mistake.)
I’m not sure anyone’s noticed, or is even all that interested, but another private company ISS has also taken over the running of the Royal Marsden NHS Trust which specialises in cancer care – and included in the deal was the world renowned UK Institute of Cancer Research.
The ICR is (was?) one of the world’s most influential cancer research institutes and has (had?) charitable status. It is (was?) listed as one of the top four cancer centres in the world. It operates (operated?) as a charitable status and in its mission statement it states (stated?) that its research is for public benefit not private…
View original post 217 more words